1 August 2024 false Taxfiler 2024.6 true 13519036 business:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 13519036 2024-07-31 13519036 2024-08-01 2025-07-31 13519036 business:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 13519036 business:FilletedAccounts 2024-08-01 2025-07-31 13519036 2025-07-31 13519036 business:Director1 2024-08-01 2025-07-31 13519036 business:Director2 2024-08-01 2025-07-31 13519036 business:RegisteredOffice 2024-08-01 2025-07-31 13519036 2024-07-31 13519036 core:WithinOneYear 2025-07-31 13519036 core:WithinOneYear 2024-07-31 13519036 core:ShareCapital core:PreviouslyStatedAmount 2025-07-31 13519036 core:ShareCapital core:PreviouslyStatedAmount 2024-07-31 13519036 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-07-31 13519036 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-07-31 13519036 core:PreviouslyStatedAmount 2025-07-31 13519036 core:PreviouslyStatedAmount 2024-07-31 13519036 business:SmallEntities 2024-08-01 2025-07-31 13519036 countries:EnglandWales 2024-08-01 2025-07-31 13519036 core:MotorVehicles 2024-08-01 2025-07-31 13519036 core:ComputerEquipment 2024-08-01 2025-07-31 13519036 core:MotorVehicles 2024-07-31 13519036 core:ComputerEquipment 2024-07-31 13519036 core:MotorVehicles 2025-07-31 13519036 core:ComputerEquipment 2025-07-31 13519036 2023-08-01 2024-07-31 iso4217:GBP xbrli:pure
Company Registration No. 13519036 (England and Wales)
Model Pharm Limited Unaudited accounts for the year ended 31 July 2025
Model Pharm Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Model Pharm Limited Company Information for the year ended 31 July 2025
Directors
Mr Oladipo Rasheed Sodunke Mr Olagoke Abdulganiu Sodunke
Company Number
13519036 (England and Wales)
Registered Office
6 SAMPHIRE ROAD OXFORD OX4 6RF ENGLAND
Accountants
Edmil Accountants UK Ltd 78A Broadway Didcot Oxfordshire OX11 8AE
- 3 -
Model Pharm Limited Statement of financial position as at 31 July 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
4,217
-
Current assets
Cash at bank and in hand
25
5,464
Creditors: amounts falling due within one year
5
(15,010)
(9,978)
Net current liabilities
(14,985)
(4,514)
Net liabilities
(10,768)
(4,514)
Capital and reserves
Called up share capital
1
1
Profit and loss account
(10,769)
(4,515)
Shareholders' funds
(10,768)
(4,514)
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 16 April 2026 and were signed on its behalf by
Mr Oladipo Rasheed Sodunke Director Company Registration No. 13519036
- 4 -
Model Pharm Limited Notes to the Accounts for the year ended 31 July 2025
1
Statutory information
Model Pharm Limited is a private company, limited by shares, registered in England and Wales, registration number 13519036. The registered office is 6 SAMPHIRE ROAD, OXFORD, OX4 6RF, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
25% SLM
Computer equipment
33.33 % SLM
Going concern
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
4
Tangible fixed assets
Motor vehicles
Computer equipment
Total
£
£
£
Cost or valuation
At cost
At cost
At 1 August 2024
-
-
-
Additions
3,999
1,062
5,061
At 31 July 2025
3,999
1,062
5,061
Depreciation
Charge for the year
667
177
844
At 31 July 2025
667
177
844
Net book value
At 31 July 2025
3,332
885
4,217
- 5 -
Model Pharm Limited Notes to the Accounts for the year ended 31 July 2025
5
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
637
-
Other creditors
2,280
-
Loans from directors
11,443
9,328
Accruals
650
650
15,010
9,978
6
Transactions with related parties
At year end, the Company owed the sum of £11,443 (FY:2024 - £9,328 ) to the Director Mr Oladipo Rasheed Sodunke.
7
Average number of employees
During the year the average number of employees was 2 (2024: 1).
- 6 -